Why Blocking a Single Hormone Pathway Can Change Mood Before a Period

What a 5α-reductase inhibitor study reveals about progesterone, brain chemistry, and PMDD symptoms

There is a common assumption in hormone health that symptoms come from levels being too high or too low.

But what if the problem is not the level itself, but how the body processes it?

Premenstrual dysphoric disorder (PMDD) offers a clear example of this. Women with PMDD often have normal hormone levels, yet experience severe mood symptoms in the luteal phase of the menstrual cycle. This disconnect has led researchers to look beyond hormones alone and toward how those hormones are metabolized and interpreted by the brain.

One pathway in particular has drawn attention: the conversion of progesterone into a neurosteroid called allopregnanolone.